INTRODUCTION
The documented history of feline herpesvirus (FHV) is recent, and disease associated with this virus was first described in domestic cats in 1958 2 . The first published reports of infection with FHV and clinical disease in wild felids appeared in the same year, i.e. 1970. One report documents cases in cheetahs in New South Wales 9 from which the virus was isolated, and the other cases in different felid species in the Cincinnati Zoo, Ohio 8 , although the virus was not isolated in the latter instance.
The 2nd documented isolation of FHV from a wild felid species was from clouded leopards in a colony in the St Louis Zoo, Missouri in 1977 1 . Further isolations in the same collection followed. One of these was from the ocular secretions of a 1-year-old female cheetah in 1984, and the other from a biopsy specimen of a cutaneous ulcer of one of her 7.5-month-old cubs in 1987 4 . Scherba and co-workers compared the latter isolate (ChHV) with feline herpesvirus type 1 (FHV-1) 5 . Antigenic comparison by serum neutralisation test with goat anti-FHV-1 serum revealed no significant differences between the 2 viruses. Similarly, there were no morphological differences observed in transmission electron micrographs and in the cytopathic effects in cell cultures. Based on the electrophoretic profiles of restriction endonucleasedigested DNA of FHV-1 and ChHV, an extensive degree of homology was found, although there was some restriction fragment length polymorphism. These results suggested that ChHV is a strain of FHV-1.
Truyen et al. 10 isolated FHV from the tonsil of a lion that was one of several lions and tigers that had died in a German safari park in 1990 after showing nervous signs. Histopathological examination and other laboratory tests did not incriminate FHV as the cause of the illness and mortality, and an aetiological diagnosis was not made.
Clinical disease in wild felids following infection with FHV has so far been described only in captive populations, although serological surveillance among free-living lions in South Africa has revealed high levels of exposure to the virus 11 .
CASE HISTORY
During April/May 1997, upper respiratory tract infection was diagnosed in 18 cheetahs in a breeding facility. The affected animals were kept in groups of 2-6 in fenced camps approximately 320 m 2 in extent in unspoilt savanna. All the cheetahs were vaccinated annually with attenuated vaccine against FHV-1, feline calicivirus (FCV) and feline panleukopenia virus, some as recently as 8 months before the appearance of clinical signs.
A variety of clinical signs were seen that included listlessness, sneezing, nasal discharge, ocular discharge, salivation, anorexia, ulcerative rhinitis and ulcerative conjunctivitis. Pneumonia was diagnosed in 2 cheetahs. The clinical signs in the remaining 16 animals were of a milder nature and were essentially sneezing and isolated instances of inappetence. One animal exhibited severe ulcerations of the tongue, salivation and inappetence but did not sneeze or show evidence of nasal discharge. Another suffered from a unilateral ulcerative conjunctivitis and bouts of sneezing.
Most of the cheetahs were caught in a cage and blood collected from the saphenous vein without immobilisation. The remainder were immobilised by administration by dart of Domitor (medetomidine HCl) at a dosage rate of 50 µg/kg (Novartis Animal Health) and ketamine at 3 mg/kg (Kyron Laboratories). After bleeding, those darted were given Antisedan (atipamizole HCl) at 200 µg/kg intramuscularly (Novartis Animal Health) to reverse the effect of the medetomidine.
Sterile cotton-tipped swabs were used to collect mucus and cells by deep insertion into the nasal cavities of 10 cheetahs. The swabs were thereafter immediately placed in minimum essential medium containing 5 % foetal bovine serum plus antibiotics, and stored in liquid nitrogen. Following transport to the laboratory, the swabs were stored at -80 °C.
Antibodies against FHV and FCV were detected by indirect fluorescent antibody (IFA) tests. The target antigens used in the preparation of antigen slides were field strains of herpes-and calicivirus isolated from domestic cats that had shown clinical signs of respiratory tract infection. They were identified by means of specific conjugated antisera (VMRD Inc., USA), and obtained from the Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria.
The transport media containing the swabs were thawed and vortexed and the swabs discarded. Aliquots of the transport fluid were inoculated into plastic tissue culture flasks containing monolayers of Crandell feline kidney cells (CrFK) and incubated at 37 °C.
Results of the IFA tests for antibodies against FHV-1 and FCV in 7 of the 18 sick animals are shown in Table 1 .
Results of the IFA test for antibodies against FHV-1 and FCV in a group of vaccinated, healthy subadult cheetahs bled during the outbreak of respiratory disease are shown in Table 2 .
Cytopathic effects compatible with herpesviruses were noticed in all cell cultures within 24 hours of inoculation. Viruses were identified by (1) the nature of the cytopathic effect on host cells, (2) electron microscopic examination of cell culture fluid, and (3) the direct fluorescent antibody test using fluoresceinconjugated FHV-1-specific antibodies (VMRD Inc., USA).
DISCUSSION
Most of the cheetahs affected by the disease stopped eating for 3-5 days, and the condition of the 2 animals that suffered from pneumonia gave reason for concern. Nevertheless, none of the cheetahs were hospitalised or required administration of parenteral fluids or force-feeding. All the affected animals received supportive treatment in the form of antibiotics for 2 weeks, and it took at least 14 days before all clinical signs had disappeared.
The results of the IFA tests of 5 of the 7 cheetahs that showed clinical evidence of upper respiratory tract infection and of 1 of the 12 apparently healthy animals are consistent with those that develop after natural exposure to FHV-1. The anti-FCV antibody titres of both the sick and healthy groups are similar to vaccination titres that are consistently monitored in cheetahs at this facility.
The current perception is that FHV infection in free-ranging felids is benign. This outbreak in semi-captive cheetahs occurred in a population that was apparently not subjected to environmental stress or population pressure. It suggests, however, that even though living conditions may seem comfortable, cheetahs living in an environment where exercise is restricted, prey is limited or absent, and contact with other predators cannot be avoided altogether, may be maladapted to captivity, which in turn may contribute to susceptibility to a viral infection despite annual vaccination. The role of confinement stress in the pathogenesis of disease conditions in cheetahs is the focus of current research.
In domestic cats the major method of spread of FHV is by direct animal-toanimal contact 3 . Although several camps housing the cheetahs were separated from each other by wire fences, the virus could only have successfully spread from the animals affected first, by crossing 2 roads 4 m and 6 m in width, respectively.
Owing to the high susceptibility of FHV to high temperatures and dry environments, mechanical transmission by flies might have played a role, although transmission by means of animal handlers or feed containers cannot be discounted.
Immunity to herpesviruses in all species, whether induced by wild strains or vaccine strains, is characteristically short-lived, and this, together with viral latency, determines its variable clinical expression and makes treatment and prevention of herpesvirus infections difficult 3 . Captive and semi-captive cheetahs have been vaccinated with attenuated vaccines in South Africa for several years without adverse effects having been reported 6, 7 . Until the time of the outbreak reported here, annual vaccination has been regarded as adequate to provide protection from clinical disease. It seems, however, that severe virus challenge, which apparently occurred in this outbreak, can overcome vaccinal immunity against feline herpesvirus-induced clinical disease in cheetahs. 
